AbbVie: 3 Positives From The Earnings Report

Since I last checked on pharmaceutical company AbbVie Inc. (NYSE: ABBV ) in August, its share price hasn't gone anywhere. But the release of its third quarter (Q3 2024) results shows investors are happy Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants , takes th ...